NCT07155278 - Efficacy & Safety of hADM Skin Booster | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 21, 2024

Primary Completion Date

May 7, 2025

Study Completion Date

May 7, 2025

Conditions

RhytidesSkin Texture IrregularitiesPhotoaged Facial SkinSkin Lifting and Tightening

Interventions

DRUG

Elravie Re2O

Elravie Re2O is a particulated human Acellular Dermal Matrix (phADM), with each 5 mL syringe containing 150 mg of phADM. This product is classified as a human tissue product and received its approval via a tissue bank establishment permit from the Ministry of Food and Drug Safety.

DRUG

Elravie Balance

Elravie Balance is a gel-type hyaluronic acid (HA) skin booster. It contains HA at a concentration of 20mg/ml in a 2.5 cc syringe with a volume of 1.5 mL.

Trial Locations (1)

03722

Severance Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors

collaborator

Korea International Cooperation Agency (KOICA)

UNKNOWN

lead

Yonsei University

OTHER